1. Home
  2. ARTV vs MTEN Comparison

ARTV vs MTEN Comparison

Compare ARTV & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • MTEN
  • Stock Information
  • Founded
  • ARTV 2019
  • MTEN 2015
  • Country
  • ARTV United States
  • MTEN China
  • Employees
  • ARTV N/A
  • MTEN N/A
  • Industry
  • ARTV
  • MTEN Building Products
  • Sector
  • ARTV
  • MTEN Industrials
  • Exchange
  • ARTV NYSE
  • MTEN Nasdaq
  • Market Cap
  • ARTV 61.9M
  • MTEN 97.9M
  • IPO Year
  • ARTV 2024
  • MTEN 2024
  • Fundamental
  • Price
  • ARTV $1.93
  • MTEN $11.90
  • Analyst Decision
  • ARTV Strong Buy
  • MTEN
  • Analyst Count
  • ARTV 7
  • MTEN 0
  • Target Price
  • ARTV $19.17
  • MTEN N/A
  • AVG Volume (30 Days)
  • ARTV 147.5K
  • MTEN 83.7K
  • Earning Date
  • ARTV 05-08-2025
  • MTEN 04-30-2025
  • Dividend Yield
  • ARTV N/A
  • MTEN N/A
  • EPS Growth
  • ARTV N/A
  • MTEN N/A
  • EPS
  • ARTV N/A
  • MTEN N/A
  • Revenue
  • ARTV N/A
  • MTEN $10,120,257.00
  • Revenue This Year
  • ARTV N/A
  • MTEN N/A
  • Revenue Next Year
  • ARTV N/A
  • MTEN N/A
  • P/E Ratio
  • ARTV N/A
  • MTEN N/A
  • Revenue Growth
  • ARTV N/A
  • MTEN 23.03
  • 52 Week Low
  • ARTV $1.78
  • MTEN $1.81
  • 52 Week High
  • ARTV $17.31
  • MTEN $16.60
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • MTEN N/A
  • Support Level
  • ARTV N/A
  • MTEN N/A
  • Resistance Level
  • ARTV N/A
  • MTEN N/A
  • Average True Range (ATR)
  • ARTV 0.00
  • MTEN 0.00
  • MACD
  • ARTV 0.00
  • MTEN 0.00
  • Stochastic Oscillator
  • ARTV 0.00
  • MTEN 0.00

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: